Covaxin Vaccine Shows Long-Term Antibody Response, Says Bharat Biotech

Covaxin, a COVID-19 vaccine being developed by Bharat Biotech, showed long-term antibody and T-cell (immune) memory responses three months after the shot in phase 1 volunteers and tolerable safety...